Treace Medical (TMCI) Form 4: Officer disposes 984; owns 548,281

Treace Medical Concepts (TMCI) reported an insider Form 4 for its Chief Legal & Compliance Officer and Corporate Secretary.

Rhea-AI Filing Summary

Treace Medical Concepts (TMCI) reported an insider Form 4 for its Chief Legal & Compliance Officer and Corporate Secretary. On 10/25/2025, the filer disposed of 984 shares of common stock at $0 under transaction code F. Following the transaction, the filer beneficially owned 548,281 shares directly. A footnote states this figure includes 426,170 restricted stock units.

Insider Trade Summary

Exercise Price or Tax Liability: 984 shares

Exercise Price or Tax Liability 1 txn

Insider Elder Scot Michael

Role Chief Legl & Comp Off, CorpSec

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	984	$0.00	$0.00

Holdings After Transaction: Common Stock — 548,281 shares (Direct)

Footnotes (1)

1. F1. Includes 426,170 restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TMCI's insider report on this Form 4?

A transaction on 10/25/2025 disposing of 984 common shares at $0 under code F.

How many TMCI shares does the reporting person own after the transaction?

Beneficial ownership is 548,281 shares, held directly.

Does the reported ownership include RSUs?

Yes. A footnote states it includes 426,170 restricted stock units.

What is the reporting person’s role at TMCI?

The filer is an Officer: Chief Legal & Compliance Officer and Corporate Secretary.

What security was involved in the transaction?

Common Stock of Treace Medical Concepts, Inc. (TMCI).

Was the ownership held directly or indirectly?

The filing reports Direct (D) ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/28/2025 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elder Scot Michael

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FL 32081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legl & Comp Off, CorpSec

3. Date of Earliest Transaction (Month/Day/Year)
10/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/25/2025		F		984	D	$0	548,281(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 426,170 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Scot Elder	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.